The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
Open accessAbstract
The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses significant challenges in the treatment of healthcare associated infections. An important advancement, is a handful of recently launched new antibiotics targeting some of the current most problematic Gram-negative pathogens, namely Carbapenem -producing Enterobacteriaceae (CRE) and Carbapenem-resistant P. aeruginosa (CRPA). Less options are available against carbapenem-resistant Acinetobacter baumannii (CRAB) and strains producing metallo-beta lactamases (MBL). Ceftazidime-avibactam signalled a turning point in the treatment of KPC and partly OXA- type carbapenemases, whereas meropenem-vaborbactam was added as a potent combination against KPC-producers. Ceftolozane-tazobactam could be seen as an ideal beta-lactam backbone for the treatment of CRPA. Plazomicin, an aminoglycoside with better pharmacokinetics and less toxicity compared to other class members, will cover important proportions of multi-drug resistant pathogens. Eravacycline holds promise in the treatment of infections by CRAB, with a broad spectrum of activity similar to tigecycline and improved pharmacokinetics. Novel drugs and combinations are not to be considered “panacea” for the ongoing crisis in the therapy of XDR Gram-negative bacteria and colistin will continue to be considered as a fundamental companion drug for the treatment of carbapenem-resistant Enterobacteriaceae (particularly in areas where MBL predominate), for the treatment of CRPA (in many cases being the only in vitro active drug) as well as CRAB. Aminoglycosides are still important companion antibiotics. Finally, fosfomycin as part of combination treatment for CRE infections and P. aeruginosa, deserves a greater attention. Optimal conditions for monotherapy and the “when and how” of combination treatments integrating the novel agents will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Self-citationAminoglycosides: Nephrotoxicity
Mingeot-Leclercq, M.-P., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1003 · Cited by 757
Grundmann, H., Glasner, C., Albiger, B., Aanensen, D. M., Tomlinson, C. T., Andrasević, A. T., Cantón, R., Carmeli, Y., Friedrich, A. W., Giske, C. G., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30257-2 · Cited by 662
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
Paul, M., Daikos, G. L., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, Y. D., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30099-9 · Cited by 623
Daikos, G. L., Tsaousi, S., Tzouvelekis, L. S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., Stefanou, I., Sypsa, V., Miriagou, V., Nepka, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02166-13 · Cited by 597
Gutiérrez-Gutiérrez, B., Salamanca, E., de Cueto, M., Hsueh, P.-R., Viale, P., Paño-Pardo, J. R., Venditti, M., Tumbarello, M., Daikos, G., Cantón, R., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30228-1 · Cited by 512
Self-citationTumbarello, M., Trecarichi, E. M., De Rosa, F. G., Giannella, M., Giacobbe, D. R., Bassetti, M., Losito, A. R., Bartoletti, M., Del Bono, V., Corcione, S., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv086 · Cited by 511
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Potoski, B. A., Marini, R. V., Doi, Y., Kreiswirth, B. N., & Clancy, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-17 · Cited by 495
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
Self-citationMechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
Wunderink, R. G., Giamarellos-Bourboulis, E. J., Rahav, G., Mathers, A. J., Bassetti, M., Vazquez, J., Cornely, O. A., Solomkin, J., Bhowmick, T., Bishara, J., et al. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0214-1 · Cited by 461
Torres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw504 · Cited by 419
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Durante-Mangoni, E., Signoriello, G., Andini, R., Mattei, A., De Cristoforo, M., Murino, P., Bassetti, M., Malacarne, P., Petrosillo, N., Galdieri, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit253 · Cited by 405
Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Wagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., Yates, K., & Gasink, L. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw378 · Cited by 362
Tumbarello, M., Trecarichi, E. M., Corona, A., De Rosa, F. G., Bassetti, M., Mussini, C., Menichetti, F., Viscoli, C., Campoli, C., Venditti, M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy492 · Cited by 354
Lomovskaya, O., Sun, D., Rubio-Aparicio, D., Nelson, K., Tsivkovski, R., Griffith, D. C., & Dudley, M. N. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-17 · Cited by 353
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
Miriagou, V., Cornaglia, G., Edelstein, M., Galani, I., Giske, C. G., Gniadkowski, M., Malamou-Lada, E., Martinez-Martinez, L., Navarro, F., Nordmann, P., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03116.x · Cited by 350
Doi, Y., Wachino, J.-I., & Arakawa, Y. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.011 · Cited by 341
Kaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Kreiswirth, B. N., & Clancy, C. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02497-17 · Cited by 289
Multidrug-Resistant Gram-Negative Infections: What are the Treatment Options?
Giamarellou, H., & Poulakou, G. (2009) · Drugs · doi:10.2165/11315690-000000000-00000 · Cited by 288
Self-citationHaidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach
Bassetti, M., Poulakou, G., Ruppe, E., Bouza, E., Van Hal, S. J., & Brink, A. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4878-x · Cited by 277
Self-citationSolomkin, J., Evans, D., Slepavicius, A., Lee, P., Marsh, A., Tsai, L., Sutcliffe, J. A., & Horn, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.4237 · Cited by 276
Dosing guidance for intravenous colistin in critically-ill patients.
Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw839 · Cited by 262
Cabot, G., Bruchmann, S., Mulet, X., Zamorano, L., Moyà, B., Juan, C., Haussler, S., & Oliver, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02462-13 · Cited by 247
De Pascale, G., Montini, L., Pennisi, M. A., Bernini, V., Maviglia, R., Bello, G., Spanu, T., Tumbarello, M., & Antonelli, M. (2014) · Critical Care · doi:10.1186/cc13858 · Cited by 245
Sirijatuphat, R., & Thamlikitkul, V. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02435-13 · Cited by 235
Ramirez, J., Dartois, N., Gandjini, H., Yan, J. L., Korth-Bradley, J., & McGovern, P. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01232-12 · Cited by 231
Monaco, M., Giani, T., Raffone, M., Arena, F., Garcia-Fernandez, A., Pollini, S., Network EuSCAPE-Italy, C., Grundmann, H., Pantosti, A., & Rossolini, G. M. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.42.20939 · Cited by 226
Solomkin, J. S., Gardovskis, J., Lawrence, K., Montravers, P., Sway, A., Evans, D., & Tsai, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1029 · Cited by 222
Pontikis, K., Karaiskos, I., Bastani, S., Dimopoulos, G., Kalogirou, M., Katsiari, M., Oikonomou, A., Poulakou, G., Roilides, E., & Giamarellou, H. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.010 · Cited by 220
Self-citationDaikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00782-08 · Cited by 210
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
Zhanel, G. G., Lawson, C. D., Zelenitsky, S., Findlay, B., Schweizer, F., Adam, H., Walkty, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.25 · Cited by 201
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Bulik, C. C., & Nicolau, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01420-10 · Cited by 200
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
Taccone, F. S., Laterre, P.-F., Spapen, H., Dugernier, T., Delattre, I., Layeux, B., De Backer, D., Wittebole, X., Wallemacq, P., Vincent, J.-L., et al. (2010) · Critical Care · doi:10.1186/cc8945 · Cited by 199
Haidar, G., Clancy, C. J., Shields, R. K., Hao, B., Cheng, S., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02534-16 · Cited by 193
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
McKinnell, J. A., Dwyer, J. P., Talbot, G. H., Connolly, L. E., Friedland, I., Smith, A., Jubb, A. M., Serio, A. W., Krause, K. M., & Daikos, G. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1807634 · Cited by 180
Samonis, G., Maraki, S., Karageorgopoulos, D. E., Vouloumanou, E. K., & Falagas, M. E. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1360-5 · Cited by 177
Management of KPC-producing Klebsiella pneumoniae infections
Bassetti, M., Giacobbe, D. R., Giamarellou, H., Viscoli, C., Daikos, G. L., Dimopoulos, G., De Rosa, F. G., Giamarellos-Bourboulis, E. J., Rossolini, G. M., Righi, E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.030 · Cited by 175
Self-citationKollef, M. H., Ricard, J.-D., Roux, D., Francois, B., Ischaki, E., Rozgonyi, Z., Boulain, T., Ivanyi, Z., János, G., Garot, D., et al. (2017) · Chest · doi:10.1016/j.chest.2016.11.026 · Cited by 173
Castanheira, M., Huband, M. D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00567-17 · Cited by 170
Zusman, O., Altunin, S., Koppel, F., Dishon Benattar, Y., Gedik, H., & Paul, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw377 · Cited by 169
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Nation, R. L., Garonzik, S. M., Li, J., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Paterson, D. L., Turnidge, J. D., Forrest, A., & Silveira, F. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ964 · Cited by 168
Task force on management and prevention of Acinetobacter baumannii infections in the ICU
Garnacho-Montero, J., Dimopoulos, G., Poulakou, G., Akova, M., Cisneros, J. M., De Waele, J., Petrosillo, N., Seifert, H., Timsit, J. F., Vila, J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4079-4 · Cited by 167
Self-citationRello, J., Solé-Lleonart, C., Rouby, J.-J., Chastre, J., Blot, S., Poulakou, G., Luyt, C.-E., Riera, J., Palmer, L. B., Pereira, J. M., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.04.011 · Cited by 167
Self-citationSun, D., Rubio-Aparicio, D., Nelson, K., Dudley, M. N., & Lomovskaya, O. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01694-17 · Cited by 166
Pournaras, S., Vrioni, G., Neou, E., Dendrinos, J., Dimitroulia, E., Poulou, A., & Tsakris, A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.031 · Cited by 163
Bassetti, M., Castaldo, N., Cattelan, A., Mussini, C., Righi, E., Tascini, C., Menichetti, F., Mastroianni, C. M., Tumbarello, M., Grossi, P., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.001 · Cited by 162
Shaw, E., Rombauts, A., Tubau, F., Padullés, A., Càmara, J., Lozano, T., Cobo-Sacristán, S., Sabe, N., Grau, I., Rigo-Bonnin, R., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx496 · Cited by 159
Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., & Paul, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm193 · Cited by 158
Castón, J. J., Lacort-Peralta, I., Martín‐Dávila, P., Loeches, B., Tabares, S., Temkin, L., Torre‐Cisneros, J., & Paño‐Pardo, J. R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.03.021 · Cited by 154
Xiao, A. J., Miller, B. W., Huntington, J. A., & Nicolau, D. P. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.566 · Cited by 152
Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00436-16 · Cited by 152
Sousa, A., Pérez-Rodríguez, M. T., Soto, A., Rodríguez, L., Pérez‐Landeiro, A., Martínez-Lamas, L., Nodar, A., & Casal, M. C. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky295 · Cited by 148
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Quale, J. M., & Landman, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-15 · Cited by 147
Farrell, D. J., Sader, H. S., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.032 · Cited by 146
Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Landman, D., & Quale, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04809-14 · Cited by 144
Munita, J. M., Aitken, S. L., Miller, W. R., Pérez, F., Rosa, R. M., Shimose, L. A., Lichtenberger, P. K., Abbo, L. M., Jain, R., Nigo, M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix014 · Cited by 142
Pfausler, B., Spiss, H., Dittrich, P., Zeitlinger, M., Schmutzhard, E., & Joukhadar, C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh158 · Cited by 140
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
Vardakas, K. Z., Legakis, N. J., Triarides, N. A., & Falagas, M. E. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.02.001 · Cited by 139
Livermore, D. M., Mushtaq, S., Meunier, D., Hopkins, K. L., Hill, R., Adkin, R., Chaudhry, A., Pike, R., Staves, P., & Woodford, N. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx136 · Cited by 139
Nicolau, D. P., Siew, L. Q. C., Armstrong, J. M., Li, J., Edeki, T. I., Learoyd, M., & Das, S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv170 · Cited by 135
Castanheira, M., Rhomberg, P. R., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00711-16 · Cited by 135
Satlin, M. J., Kubin, C. J., Blumenthal, J. S., Cohen, A. B., Furuya, E. Y., Wilson, S. J., Jenkins, S. G., & Calfee, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-11 · Cited by 132
Popejoy, M. W., Paterson, D. L., Cloutier, D. J., Huntington, J. A., Miller, B. W., Bliss, C. A., Steenbergen, J. N., Hershberger, E., Umeh, O., & Kaye, K. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw374 · Cited by 129
Giamarellou, H., Galani, L., Baziaka, F., & Karaiskos, I. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02399-12 · Cited by 125
Self-citationColistin: still a lifesaver for the 21st century?
Karaiskos, I., Souli, M., Galani, I., & Giamarellou, H. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1230200 · Cited by 125
Self-citationDickstein, Y., Lellouche, J., Dalak, M. A. B., Schwartz, D. A., Nutman, A., Daitch, V., Yahav, D., Leibovici, L., Skiada, A., Antoniadou, A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy988 · Cited by 125
Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-09 · Cited by 118
Chandorkar, G., Huntington, J. A., Gotfried, M. H., Rodvold, K. A., & Umeh, O. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks246 · Cited by 118
Connors, K. P., Housman, S. T., Pope, J. S., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02036-13 · Cited by 117
Pérez, A., Gato, E., Pérez-Llarena, J., Fernández-Cuenca, F., Gude, M. J., Oviaño, M., Pachón, M. E., Garnacho, J., González, V., Pascual, Á., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz030 · Cited by 117
Walkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Karaiskos, I., Friberg, L. E., Pontikis, K., Ioannidis, K., Tsagkari, V., Galani, L., Kostakou, E., Baziaka, F., Paskalis, C., Koutsoukou, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00554-15 · Cited by 113
Self-citationTigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
Ni, W., Han, Y., Liu, J., Wei, C., Zhao, J., Cui, J., Wang, R., & Liu, Y.-N. (2016) · Medicine · doi:10.1097/md.0000000000003126 · Cited by 112
de Montmollin, É., Bouadma, L., Gault, N., Mourvillier, B., Mariotte, É., Chemam, S., Massias, L., Papy, E., Tubach, F., Wolff, M., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3276-x · Cited by 111
Dalfino, L., Puntillo, F., Ondok, M. J. M., Mosca, A., Monno, R., Coppolecchia, S., Spada, M. L., Bruno, F., & Brienza, N. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ717 · Cited by 108
Seifert, H., Stefanik, D., Sutcliffe, J. A., & Higgins, P. G. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.022 · Cited by 108
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
Burkhardt, O., Rauch, K., Kaever, V., Hadem, J., Kielstein, J. T., & Welte, T. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.01.015 · Cited by 106
Stein, C., Makarewicz, O., Bohnert, J. A., Pfeifer, Y., Kesselmeier, M., Hagel, S., & Pletz, M. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126479 · Cited by 105
González-Padilla, M., Torre‐Cisneros, J., Rivera-Espinar, F., Pontes-Moreno, A., López‐Cerero, L., Pascual, Á., Natera, C., Rodriguez, M., Salcedo-Leal, I., Rodríguez-López, F., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku432 · Cited by 104
Levasseur, P., Girard, A.-M., Claudon, M., Goossens, H., Black, M. T., Coleman, K., & Miossec, C. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06064-11 · Cited by 102
Compain, F., & Arthur, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00451-17 · Cited by 101
Falagas, M. E., Vardakas, K. Z., Tsiveriotis, K., Triarides, N. A., & Tansarli, G. S. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.006 · Cited by 97
Galani, I., Souli, M., Daikos, G. L., Chryssouli, Z., Poulakou, G., Psichogiou, M., Panagea, T., Argyropoulou, A., Stefanou, I., Plakias, G., et al. (2012) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000015 · Cited by 96
Self-citationGalani, I., Karaiskos, I., Karantani, I., Papoutsaki, V., Maraki, S., Papaioannou, V., Kazila, P., Tsorlini, H., Charalampaki, N., Toutouza, M. G., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.30.1700775 · Cited by 93
Self-citationKaraiskos, I., Galani, I., Souli, M., & Giamarellou, H. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1563071 · Cited by 92
Self-citationSader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
PASCALE, G. D., Martucci, G., Montini, L. M., Panarello, G., Cutuli, S. L., Carlo, D. D., Gravio, V. D., Stefano, R. D., Capitanio, G., Vallecoccia, M. S., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1769-z · Cited by 81
Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing β-Lactamase
Alba, J., Ishii, Y., Thomson, K. S., Moland, E. S., & Yamaguchi, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4760-4762.2005 · Cited by 80
Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study
Paquette, F., Bernier-Jean, A., Brunette, V., Ammann, H., Lavergne, V., Pichette, V., Troyanov, S., & Bouchard, J. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000440867 · Cited by 80
Mojica, M. F., Ouellette, C. P., Leber, A. L., Becknell, B., Ardura, M. I., Pérez, F., Shimamura, M., Bonomo, R. A., Aitken, S. L., & Shelburne, S. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00264-16 · Cited by 80
Torres, A., Niederman, M. S., Chastre, J. E., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M. H., Bassi, G. L., Luna, C. M., Martín‐Loeches, I., et al. (2018) · ERJ Open Research · doi:10.1183/23120541.00028-2018 · Cited by 79
Pharmacokinetic and pharmacodynamic evaluation of tigecycline
Giamarellou, H., & Poulakou, G. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.623126 · Cited by 78
Self-citationRoger, C., Nucci, B., Louart, B., Friggeri, A., Knani, H., Evrard, A., Lavigne, J., Allaouchiche, B., Lefrant, J., Roberts, J. A., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv291 · Cited by 77
Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
Parker, S. L., Frantzeskaki, F. G., Wallis, S. C., Diakaki, C., Giamarellou, H., Koulenti, D., Karaiskos, I., Lipman, J., Dimοpoulos, G., & Roberts, J. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01321-15 · Cited by 76
Self-citationParker, S. L., Lipman, J., Koulenti, D., Dimοpoulos, G., & Roberts, J. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.05.018 · Cited by 75
Giannella, M., Trecarichi, E. M., Giacobbe, D. R., Rosa, F. G. D., Bassetti, M., Bartoloni, A., Bartoletti, M., Losito, A. R., Bono, V. D., Corcione, S., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.08.019 · Cited by 75
Poirel, L., Kieffer, N., & Nordmann, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv294 · Cited by 70
Roger, C., Nucci, B., Molinari, N., Bastide, S., Saïssi, G., Pradel, G., Barbar, S. D., Aubert, C., Lloret, S., Elotmani, L., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.009 · Cited by 66
Daikos, G. L., Markogiannakis, A., Souli, M., & TZOUVELEKIS, L. S. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.138 · Cited by 66
Sader, H. S., Castanheira, M., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02083-16 · Cited by 65
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
Berçot, B., Poirel, L., Dortet, L., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr296 · Cited by 62
Rational approach in the management of Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Russo, A., Croxatto, A., Calandra, T., & Guery, B. P. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000505 · Cited by 62
Alexander, B. T., Marschall, J., Tibbetts, R. J., Neuner, E. A., Dunne, W. M., & Ritchie, D. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.05.002 · Cited by 60
Karageorgopoulos, D. E., Miriagou, V., TZOUVELEKIS, L. S., Spyridopoulou, K., & Daikos, G. L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks270 · Cited by 60
Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections
Escolà‐Vergé, L., Pigrau, C., Arcos, I. L., Arévalo, Á., Viñado, B., Campany, D., Larrosa, N., Nuvials, X., Ferrer, R., Len, Ó., et al. (2018) · Infection · doi:10.1007/s15010-018-1133-5 · Cited by 60
Castanheira, M., Costello, S. E., Woosley, L. N., Deshpande, L. M., Davies, T. A., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03930-14 · Cited by 59
Hirsch, E. B., Guo, B., Chang, K., Cao, H., Ledesma, K. R., Singh, M., & Tam, V. H. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis766 · Cited by 59
Souli, M., Karaiskos, I., Masgala, A., Galani, L., Barmpouti, E., & Giamarellou, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2936-5 · Cited by 59
Self-citationZhong, H., Zhao, X., Zhang, Z.-L., Gu, Z., Zhang, C., Gao, Y., & Cui, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.07.004 · Cited by 57
Eravacycline for the treatment of intra-abdominal infections
Bassetti, M., & Righi, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.965253 · Cited by 53
Combination Antimicrobial Treatment Versus Monotherapy: The Contribution of Meta-analyses
Paul, M., & Leibovici, L. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.01.004 · Cited by 53
Betts, J. W., Phee, L. M., Hornsey, M., Woodford, N., & Wareham, D. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02449-14 · Cited by 52
Flamm, R. K., Sader, H. S., Farrell, D. J., & Jones, R. N. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.005 · Cited by 50
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae
Shields, R. K., Clancy, C. J., Press, E. G., & Nguyen, M. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02638-15 · Cited by 49
Tendon, V. D., Poirel, L., Connolly, L. E., Krause, K. M., & Nordmann, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx239 · Cited by 48
Albiero, J., Sy, S. K. B., Mazucheli, J., Caparroz‐Assef, S. M., Costa, B. B., Alves, J. L. B., Gales, A. C., & Tognim, M. C. B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03099-15 · Cited by 47
Combination therapy for extensively-drug resistant gram-negative bacteria
Karaiskos, I., Antoniadou, A., & Giamarellou, H. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1410434 · Cited by 47
Self-citationEravacycline (TP-434) Is Efficacious in Animal Models of Infection
Grossman, T. H., Murphy, T. M., Slee, A., Lofland, D., & Sutcliffe, J. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04354-14 · Cited by 45
Oliva, A., Scorzolini, L., Castaldi, D., Gizzi, F., Angelis, M. D., Storto, M., D’Abramo, A., Aloj, F., Mascellino, M. T., Mastroianni, C. M., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.10.002 · Cited by 45
Bremmer, D. N., Nicolau, D. P., Burcham, P. K., Chunduri, A., Shidham, G. B., & Bauer, K. A. A. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1744 · Cited by 43
Yu, W., Shen, P., Bao, Z., Zhou, K., Zheng, B., Ji, J., Guo, L., Huang, C., & Xiao, Y. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.011 · Cited by 42
Burdet, C., Pajot, O., Couffignal, C., Armand-Lefèvre, L., Foucrier, A., Laouenan, C., Wolff, M., Massias, L., & Mentré, F. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1766-y · Cited by 41
Goodlet, K. J., Nicolau, D. P., & Nailor, M. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01350-17 · Cited by 39
Xipell, M., Paredes, S., Fresco, L., Bodro, M., Marco, F., Martínez, J. A., & Soriano, À. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.01.010 · Cited by 39
Natesan, S., Pai, M. P., & Lodise, T. P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx221 · Cited by 38
Plazomicin: an investigational therapy for the treatment of urinary tract infections
Karaiskos, I., Souli, M., & Giamarellou, H. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1095180 · Cited by 37
Self-citationOliver, W. D., Heil, E. L., Gonzales, J. P., Mehrotra, S., Robinett, K. S., Saleeb, P. G., & Nicolau, D. P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02608-15 · Cited by 37
Aminoglycoside-associated acute kidney injury in elderly patients with and without shock
Ong, L., Tambyah, P. A., Lum, L. H.-W., Low, Z.-J., Cheng, I., Murali, T. M., Wan, M.-Q., & Chua, H. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw296 · Cited by 36
Xiao, A. J., Caro, L., Popejoy, M. W., Huntington, J. A., & Kullar, R. (2016) · Infectious Diseases and Therapy · doi:10.1007/s40121-016-0143-9 · Cited by 35
Diez‐Aguilar, M., Morosini, M.-I., del Campo, R., García-Castillo, M., Zamora, J., & Cantón, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00589-13 · Cited by 34
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock
Allou, N., Bouteau, A., Allyn, J., Snauwaert, A., Valance, D., Jabot, J., Bouchet, B., Galliot, R., Corradi, L., Montravers, P., et al. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0211-z · Cited by 34
New treatments of multidrug-resistant Gram-negative ventilator-associated pneumonia
Poulakou, G., Lagou, S., Karageorgopoulos, D. E., & Dimοpoulos, G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.29 · Cited by 33
Self-citationBrasseur, A., Hites, M., Roisin, S., COTTON, F. J., Vincent, J., Backer, D. D., Jacobs, F., & Taccone, F. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv491 · Cited by 30
Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges
Poulakou, G., Siakallis, G., Tsiodras, S., Arfaras-Melainis, A., & Dimopoulos, G. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268052 · Cited by 28
Self-citationAbdelraouf, K., Kim, A., Krause, K. M., & Nicolau, D. P. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01074-18 · Cited by 28
Galani, I., Nafplioti, K., Chatzikonstantinou, M., & Souli, M. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000725 · Cited by 17
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000020 · Cited by 421
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Suay-García, B., & Pérez-Gracia, M. T. (2019) · Antibiotics · doi:10.3390/antibiotics8030122 · Cited by 344
Nie, D., Hu, Y., Chen, Z., Li, M., Hou, Z., Luo, X., Mao, X., & Xue, X. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-0617-7 · Cited by 316
Morris, S., & Cerceo, E. (2020) · Antibiotics · doi:10.3390/antibiotics9040196 · Cited by 287
Metadata
- Authors
- Karaiskos, I., Lagou, S., Pontikis, K., Rapti, V., & Poulakou, G.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2019-06-11
- Volume
- 7
- Pages
- 151-151
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W2950651849
- Cited by
- 288
- References
- 156
- FWCI
- 13.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.